2026 Prescription Price Audit
Compare your prescription or pharmacy receipt with publicly available 2026 Medicare Maximum Fair Price reference information and explore possible savings options.
1. Upload or Review
Use the main AI tool to read a prescription, medication label, or pharmacy receipt and extract the visible medication information.
2. Compare References
Check whether the medication appears in the 2026 Medicare negotiated price reference list.
3. Explore Savings
Review coupon, pharmacy savings, or partner resources that may help you compare available options.
Use the AI Prescription Tool First
For the safest experience, upload your prescription or pharmacy receipt through the main tool. After the AI extracts visible medication details, you can compare savings options and reference information.
This page provides informational reference guidance only. Actual pharmacy costs may vary based on insurance coverage, eligibility, pharmacy location, formulary rules, and discount program availability.
2026 Medicare Maximum Fair Price Reference
| Drug | Common Use Category | Reference Note |
|---|---|---|
| Eliquis | Blood clot prevention / treatment | Included in the first 2026 Medicare negotiation cycle. |
| Jardiance | Diabetes / heart-related use | Included in the first 2026 Medicare negotiation cycle. |
| Xarelto | Blood clot prevention / treatment | Included in the first 2026 Medicare negotiation cycle. |
| Januvia | Diabetes | Included in the first 2026 Medicare negotiation cycle. |
| Farxiga | Diabetes / heart-related use | Included in the first 2026 Medicare negotiation cycle. |
| Entresto | Heart failure | Included in the first 2026 Medicare negotiation cycle. |
| Enbrel | Autoimmune / arthritis-related use | Included in the first 2026 Medicare negotiation cycle. |
| Imbruvica | Certain blood cancers | Included in the first 2026 Medicare negotiation cycle. |
| Stelara | Autoimmune / inflammatory conditions | Included in the first 2026 Medicare negotiation cycle. |
| Fiasp / NovoLog | Insulin | Included in the first 2026 Medicare negotiation cycle. |
Reference information is based on publicly available CMS information about the first 10 Medicare Part D drugs selected for negotiated Maximum Fair Prices effective in 2026. This website is independent and is not affiliated with CMS, Medicare, HHS, or any government agency.
Frequently Asked Questions
What is a 2026 Maximum Fair Price?
A Maximum Fair Price is a negotiated Medicare price for selected drugs under the Medicare Drug Price Negotiation Program. It applies to eligible Medicare prescription drug coverage, and actual patient costs may depend on plan design and individual circumstances.
Does this page tell me my final pharmacy price?
No. This page provides educational reference information only. Your final cost may vary depending on your insurance plan, deductible, pharmacy, location, coupon eligibility, and other factors.
Can I compare coupon savings too?
Yes. After reviewing your prescription information, you can visit the Savings Coupons section to compare available pharmacy savings options through partner resources.
Ready to Compare Your Prescription?
Start by analyzing your prescription or pharmacy receipt, then review possible savings options based on the medication information visible in your document.